Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors

Biochemistry

Volumn 46, Issue 27, 2007, Pages 8036-8049

  Wang, Dongqing ^a,b   Wang, Qi ^a,c   Awasthi, Smita ^a   Simons Jr , S Stoney ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTORS (GR); PROGESTERONE RECEPTORS (PR); RECEPTOR INTERACTION;

AMINO ACIDS; BIOACTIVITY; BIOASSAY; GENES; KETONES; MUTAGENESIS; TRANSCRIPTION;

IMMUNOLOGY;

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HORMONE RECEPTOR STIMULATING AGENT; NUCLEAR RECEPTOR COACTIVATOR 2; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AIB1; TRANSCRIPTION FACTOR NCOR; TRANSCRIPTION FACTOR SMRT; TRANSCRIPTION FACTOR SRC1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; ENHANCER REGION; GENE CONTROL; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM;

BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 34447305765     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7004575     Document Type: Article

References (65)

1. McKenna, N. J., and O'Malley, B. W. (2002) Combinatorial control of gene expression by nuclear receptors and coregulators, Cell 108, 465-474.
2. Nagy, L., and Schwabe, J. W. (2004) Mechanism of the nuclear receptor molecular switch, Trends Biochem. Sci. 29, 317-324.
3. Rosenfeld, M. G., Lunyak, V. V., and Glass, C. K. (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response, Genes Dev. 20, 1405-1428.
4. Simons, S. S., Jr. (2006) How much is enough? Modulation of dose-response curve for steroid receptor-regulated gene expression by changing concentrations of transcription factor, Curr. Top. Med. Chem. 6, 271-285.
5. Cho, S., Blackford, J. A., Jr., and Simons, S. S., Jr. (2005) Role of activation function domain 1, DNA binding, and coactivator in the expression of partial agonist activity of glucocorticoid receptor complexes, Biochemistry 44, 3547-3561.
6. Wang, D., and Simons, S. S., Jr. (2005) Corepressor binding to progesterone and glucocorticoid receptors involves the AF-1 domain and is inhibited by molybdate, Mol. Endocrinol. 19, 1483-1500.
7. Chen, J. D., and Evans, R. M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature 377, 454-457.
8. Horlein, A. J., Naar, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C. K., and Rosenfeld, M. G. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature 377, 397-404.
9. Szapary, D., Huang, Y., and Simons, S. S., Jr. (1999) Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor regulated gene expression, Mol. Endocrinol. 13, 2108-2121.
10. Giannoukos, G., Szapary, D., Smith, C. L., Meeker, J. E. W., and Simons, S. S., Jr. (2001) New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties, Mol. Endocrinol. 15, 255-270.
11. Leonhardt, S. A., and Edwards, D. P. (2002) Mechanism of action of progesterone antagonists, Exp. Biol. Med. (Maywood, NJ, U.S.) 227, 969-980.
12. Liu, Z., Auboeuf, D., Wong, J., Chen, J. D., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (2002) Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486, Proc. Natl. Acad. Sci. U.S.A. 99, 7940-7944.
13. Berrevoets, C. A., Umar, A., Trapman, J., and Brinkmann, A. O. (2004) Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR), Biochem. J. 379, 731-738.
14. Wang, Q., Blackford, J. A., Jr., Song, L.-N., Huang, Y., and Simons, S. S., Jr. (2004) Equilibrium interactions of corepressors and coactivators modulate the properties of agonist and antagonist complexes of glucocorticoid receptors, Mol. Endocrinol. 18, 1376-1395.
15. Simons, S. S., Jr. (2003) The importance of being varied in steroid receptor transactivation, TIPS 24, 253-259.
16. Wan, W., Farboud, B., and Privalsky, M. L. (2005) Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function, Mol. Endocrinol. 19, 1529-1542.
17. Voss, T. C., Demarco, I. A., Booker, C. F., and Day, R. N. (2005) Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain, Mol. Cell. Endocrinol. 231, 33-47.
18. Yoon, H. G., and Wong, J. (2006) The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor, Mol. Endocrinol. 20, 1048-1060.
19. Wu, Y., Kawate, H., Ohnaka, K., Nawata, H., and Takayanagi, R. (2006) Nuclear compartmentalization of N-CoR and its interactions with steroid receptors, Mol. Cell. Biol. 26, 6633-6655.
20. Frego, L., and Davidson, W. (2006) Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry, Protein Sci. 15, 722-730.
21. Heery, D. M., Kalkhoven, E., Hoare, S., and Parker, M. G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature 387, 733-736.
22. Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., and Yamamoto, K. R. (1998) Structure and specificity of nuclear receptor-coactivator interactions, Genes Dev. 12, 3343-3356.
23. Hu, X., and Lazar, M. A. (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors, Nature 402, 93-96.
24. Nagy, L., Kao, H.-Y., Love, J. D., Li, C., Banayo, E., Gooch, J. T., Krishna, V., Chatterjee, K., Evans, R. M., and Schwabe, J. W. R. (1999) Mechanism of corepressor binding and release from nuclear hormone receptors, Genes Dev. 13, 3209-3216.
25. Perissi, V., Staszewski, L. M., McInerney, E. M., Kurokawa, R., Krones, A., Rose, D. W., Lambert, M. H., Milburn, M. V., Glass, C. K., and Rosenfeld, M. G. (1999) Molecular determinants of nuclear receptor-corepressor interaction, Genes Dev. 13, 3198-3208.
26. Voegel, J. J., Heine, M. J. S., Tini, M., Vivat, V., Chambon, P., and Gronemeyer, H. (1998) The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways, EMBO J. 17, 507-519.
27. Hsiao, P. W., Fryer, C. J., Trotter, K. W., Wang, W., and Archer, T. K. (2003) BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation, Mol. Cell. Biol. 23, 6210-6220.
28. Hittelman, A. B., Burakov, D., Iniguez-Lluhi, J. A., Freedman, L. P., and Garabedian, M. J. (1999) Differential regulation of glucocorticoid receptor transcriptional activation via AF-1 associated proteins, EMBO J. 18, 5380-5388.
29. Lanz, R. B., McKenna, N. J., Onate, S. A., Albrecht, U., Wong, J., Tsai, S. Y., Tsai, M.-J., and O'Malley, B. W. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex, Cell 97, 17-27.
30. Ma, Y., Katiyar, P., Jones, L. P., Fan, S., Zhang, Y., Furth, P. A., and Rosen, E. M. (2006) The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells, Mol. Endocrinol. 20, 14-34.
31. He, B., Kemppainen, J. A., Voegel, J. J., Gronemeyer, H., and Wilson, E. M. (1999) Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain, J. Biol. Chem. 274, 37219-37225.
32. Onate, S. A., Boonyaratanakornkit, V., Spencer, T. E., Tsai, S. Y., Tsai, M.-J., Edwards, D. P., and O'Malley, B. W. (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors, J. Biol. Chem. 273, 12101-12108.
33. Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., and Parker, M. G. (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1, Mol. Cell. Biol. 19, 8383-8392.
34. Charmandari, E., Chrousos, G. P., Ichijo, T., Bhattacharyya, N., Vottero, A., Souvatzoglou, E., and Kino, T. (2005) The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes, Mol. Endocrinol. 19, 52-64.
35. Kumar, R., and Thompson, E. B. (2003) Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions, Mol. Endocrinol. 17, 1-10.
36. Kumar, R., Lee, J. C., Bolen, D. W., and Thompson, E. B. (2001) The conformation of the glucocorticoid receptor AF1/tau1 domain induced by osmolyte binds co-regulatory proteins, J. Biol. Chem. 276, 18146-18152.
37. Giangrande, P. H., Kimbrel, E. A., Edwards, D. P., and McDonnell, D. P. (2000) The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding, Mol. Cell. Biol. 20, 3102-3115.
38. He, Y., Szapary, D., and Simons, S. S., Jr. (2002) Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation, J. Biol. Chem. 277, 49256-49266.
39. Szapary, D., Xu, M., and Simons, S. S., Jr. (1996) Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration, J. Biol. Chem. 271, 30576-30582.
40. Ma, H., Shang, Y., Lee, D. Y., and Stallcup, M. R. (2003) Study of nuclear receptor-induced transcription complex assembly and histone modification by chromatin immunoprecipitation assays, Methods Enzymol. 364, 284-296.
41. Li, X., Kimbrel, E. A., Kenan, D. J., and MCDonnell, D. P. (2002) Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation, Mol. Endocrinol. 16, 1482-1491.
42. Schulz, M., Eggert, M., Baniahmad, A., Dostert, A., Heinzel, T., and Renkawitz, R. (2002) RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding, J. Biol. Chem. 277, 26238-26243.
43. Song, L.-N., Huse, B., Rusconi, S., and Simons, S. S., Jr. (2001) Transactivation specificity of glucocorticoid vs. progesterone receptors: role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains, J. Biol. Chem. 276, 24806-24816.
44. Simons, S. S., Jr. (1994) Function/activity of specific amino acids in glucocorticoid receptors, Vitam. Horm. 48, 49-130.
45. Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., Lambert, M. H., Moore, J. T., Pearce, K. H., and Xu, H. E. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell 110, 93-105.
46. Li, X., Wong, J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (2003) Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification, Mol. Cell. Biol. 23, 3763-3773.
47. Song, L. N., Coghlan, M., and Gelmann, E. P. (2004) Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor, Mol. Endocrinol. 18, 70-85.
48. Hodgson, M. C., Astapova, I., Cheng, S., Lee, L. J., Verhoeven, M. C., Choi, E., Balk, S. P., and Hollenberg, A. N. (2005) The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists, J. Biol. Chem. 280, 6511-6519.
49. Webb, P., Nguyen, P., and Kushner, P. J. (2003) Differential SERM effects on corepressor binding dictate ERalpha activity in vivo, J. Biol. Chem. 278, 6912-6920.
50. Zamir, I., Harding, H. P., Atkins, G. B., Horlein, A., Glass, C. K., Rosenfeld, M. G., and Lazar, M. A. (1996) A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains, Mol. Cell. Biol. 16, 5458-5465.
51. Yamamoto, Y., Wada, O., Suzawa, M., Yogiashi, Y., Yano, T., Kato, S., and Yanagisawa, J. (2001) The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes, J. Biol. Chem. 276, 42684-42691.
52. de Felipe, K. S., Carter, B. T., Althoff, E. A., and Cornish, V. W. (2004) Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system, Biochemistry 43, 10353-10363.
53. Huang, J., Li, X., Maguire, C. A., Hilf, R., Bambara, R. A., and Muyan, M. (2005) Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus, Mol. Endocrinol. 19, 2696-2712.
54. Chattopadhyay, S., Gong, E. Y., Hwang, M., Park, E., Lee, H. J., Hong, C. Y., Choi, H. S., Cheong, J. H., Kwon, H. B., and Lee, K. (2006) The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells, Mol. Endocrinol. 20, 984-995.
55. Carascossa, S., Gobinet, J., Georget, V., Lucas, A., Badia, E., Castet, A., White, R., Nicolas, J. C., Cavailles, V., and Jalaguier, S. (2006) Receptor-interacting protein 140 is a repressor of the androgen receptor activity, Mol. Endocrinol. 20, 1506-1518.
56. Georgescu, S. P., Li, J. H., Lu, Q., Karas, R. H., Brown, M., and Mendelsohn, M. E. (2005) Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha, Mol. Endocrinol. 19, 2491-2501.
57. Iankova, I., Petersen, R. K., Annicotte, J. S., Chavey, C., Hansen, J. B., Kratchmarova, I., Sarruf, D., Benkirane, M., Kristiansen, K., and Fajas, L. (2006) Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis, Mol. Endocrinol. 20, 1494-1505.
58. Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., and McDonnell, D. P. (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function, Mol. Endocrinol. 7, 1244-1255.
59. Giangrande, P. H., Pollio, G., and McDonnell, D. P. (1997) Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor, J. Biol. Chem. 272, 32889-32900.
60. Christiaens, V., Bevan, C. L., Callewaert, L., Haelens, A., Verrijdt, G., Rombauts, W., and Claessens, F. (2002) Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control, J. Biol. Chem. 277, 49230-49237.
61. Wood, J. R., Likhite, V. S., Loven, M. A., and Nardulli, A. M. (2001) Allosteric modulation of estrogen receptor conformation by different estrogen response elements, Mol. Endocrinol. 15, 1114-11126.
62. Jiang, S., Meyer, R., Kang, K., Osborne, C. K., Wong, J., and Oesterreich, S. (2006) Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor, Mol. Endocrinol. 20, 311-320.
63. Liu, P. Y., Hsieh, T. Y., Chou, W. Y., and Huang, S. M. (2006) Modulation of glucocorticoid receptor-interacting protein 1 (GRIP1) transactivation and co-activation activities through its C-terminal repression and self-association domains, FEBS J. 273, 2172-2183.
64. Reichman, M. E., Foster, C. M., Eisen, L. P., Eisen, H. J., Torain, B. F., and Simons, S. S., Jr. (1984) Limited proteolysis of covalently labeled glucocorticoid receptors as a probe of receptor structure, Biochemistry 23, 5376-5384.
65. Lu, N. Z., and Cidlowski, J. A. (2005) Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes, Mol. Cell 18, 331-342.